Results 261 to 265 of about 1,195,119 (265)

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2015
Iain B Mcinnes, Philip J Mease, Bruce W Kirkham   +2 more
exaly  

Kinase inhibitors attract attention as oral rheumatoid arthritis drugs

Nature Reviews Drug Discovery, 2010
exaly  

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

New England Journal of Medicine, 2000
Peter E Lipsky, Sofia Ramiro, Daniel E Furst   +2 more
exaly  

Septic arthritis

Lancet, The, 1998
exaly  

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

Lancet, The, 1994
exaly